Search Results - "Forte, Serene"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Early- and Intermediate-Stage Variants of Simian Immunodeficiency Virus Replicate Efficiently in Cells Lacking CCR5 by Forte, Serene, Harmon, Mary-Elizabeth, Pineda, Mario J, Overbaugh, Julie

    Published in Journal of Virology (01-09-2003)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Attenuation of human immunodeficiency virus type 1 cytopathic effects by replacing a 424-bp region of envelope from a noncytopathic biological clone by Forte, S E, Somasundaran, M, Sullivan, J L

    Published in AIDS research and human retroviruses (20-01-2000)
    “…We analyzed the env genes of cytopathic and noncytopathic biological clones derived from two HIV-1-infected children with discordant clinical courses. Chimeric…”
    Get more information
    Journal Article
  3. 3

    Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis by Bacha, P, Forte, S E, Perper, S J, Trentham, D E, Nichols, J C

    Published in European journal of immunology (01-07-1992)
    “…DAB486IL-2 is an interleukin-2 receptor-specific cytotoxin which selectively targets and kills cells which bear the high-affinity form of the IL-2 receptor…”
    Get more information
    Journal Article
  4. 4

    In vitro characterization of HIV type 1 biological clones from asymptomatic and symptomatic pediatric patients by Forte, S E, Sullivan, J L, Somasundaran, M

    Published in AIDS research and human retroviruses (20-11-1996)
    “…To investigate the mechanisms of HIV-1 cytopathogenicity, functional biological HIV-1 clones were isolated from two infected children with high viral loads in…”
    Get more information
    Journal Article
  5. 5

    Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein by Kirkman, R L, Bacha, P, Barrett, L V, Forte, S, Murphy, J R, Strom, T B

    Published in Transplantation (01-02-1989)
    “…A diphtheria toxin-related IL-2 fusion gene has been constructed that encodes a 68KD recombinant toxin in which the diphtheria toxin receptor-binding domain…”
    Get more information
    Journal Article
  6. 6

    Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancy by Bacha, P A, Forte, S E, McCarthy, D M, Estis, L, Yamada, G, Nichols, J C

    Published in International journal of cancer (19-08-1991)
    “…DAB486IL-2 is a genetically engineered fusion protein consisting of a portion of diphtheria toxin fused to human IL-2. It is specifically cytotoxic for tumor…”
    Get more information
    Journal Article
  7. 7

    Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells by Forte, S E, Byron, K S, Sullivan, J L, Somasundaran, M

    Published in AIDS research and human retroviruses (01-12-1994)
    “…Human immunodeficiency virus type 1 (HIV-1) isolates from six infected individuals less then 4 years of age were phenotyped for their syncytium-inducing (SI)…”
    Get more information
    Journal Article
  8. 8

    Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid by JACKSON, I. M. D, ADELMAN, L. S, MUNSAT, T. L, FORTE, S, LECHAN, R. M

    Published in Neurology (01-09-1986)
    “…In spinal cords from seven amyotrophic lateral sclerosis (ALS) patients and four controls, we found no difference in thyrotropin-releasing hormone (TRH)…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models by BACHA, P, FORTE, S, NASIM KASSAM, THOMAS, J, AKIYOSHI, D, WATERS, C, NICHOLS, J, ROSENBLUM, M

    Published in Cancer chemotherapy and pharmacology (01-01-1990)
    “…The kinetics of the in vitro cytotoxicity of DAB486IL-2, a genetically engineered fusion protein containing a portion of diphtheria toxin and human…”
    Get full text
    Journal Article